These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 8304906)

  • 1. An Australian experience of transdermal oestradiol patches in a subtropical climate.
    O'Neill S; Kirkegard Y
    Aust N Z J Obstet Gynaecol; 1993 Aug; 33(3):327-9. PubMed ID: 8304906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adverse skin reactions to transdermal oestradiol in tropical climate. A comparative study of skin tolerance after using oestradiol patch and gel in Thai postmenopausal women.
    Sentrakul P; Chompootaweep S; Sintupak S; Tasanapradit P; Tunsaringkarn K; Dusitsin N
    Maturitas; 1991 Jun; 13(2):151-4. PubMed ID: 1833610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of two types of estradiol-releasing skin patches for menopausal patients in a tropical climate.
    McCarthy T; Dramusic V; Ratnam S
    Am J Obstet Gynecol; 1992 Jun; 166(6 Pt 2):2005-10. PubMed ID: 1605292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized study to compare the effectiveness, tolerability, and acceptability of two different transdermal estradiol replacement therapies. The Transdermal HRT Investigators Group.
    Int J Fertil Menopausal Stud; 1993; 38(1):5-11. PubMed ID: 8485612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy on climacteric symptoms of a new estradiol transdermal patch with active matrix in comparison with a reference reservoir patch. Two long-term randomized multicenter parallel-group studies.
    Rovati LC; Schmid K; Giacovelli G; Bonn M; Setnikar I; Wolff F; Genazzani AR
    Arzneimittelforschung; 1999 Nov; 49(11):933-43. PubMed ID: 10604047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved patient acceptability with a transdermal drug-in-adhesive oestradiol patch.
    Lake Y; Pinnock S
    Aust N Z J Obstet Gynaecol; 2000 Aug; 40(3):313-6. PubMed ID: 11065040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical experience with Systen, a new transdermal form of hormone replacement therapy.
    Corson SL
    Int J Fertil Menopausal Stud; 1993; 38 Suppl 1():36-44. PubMed ID: 8499958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estradiol gel: review of the pharmacology, pharmacokinetics, efficacy, and safety in menopausal women.
    Naunton M; Al Hadithy AF; Brouwers JR; Archer DF
    Menopause; 2006; 13(3):517-27. PubMed ID: 16735950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of continuous sequential transdermal estradiol and norethindrone acetate in relieving vasomotor symptoms associated with menopause.
    Notelovitz M; Cassel D; Hille D; Furst KW; Dain MP; VandePol C; Skarinsky D
    Am J Obstet Gynecol; 2000 Jan; 182(1 Pt 1):7-12. PubMed ID: 10649149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of efficacy and local tolerability of estradiol metered-dose transdermal spray to estradiol patch in a network meta-analysis.
    Kovács G; Zelei T; Vokó Z
    Climacteric; 2016 Oct; 19(5):488-95. PubMed ID: 27593417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of gel and patch estradiol replacement in Brazil, a tropical country.
    Travassos de Figueiredo Alves ; Amélia Sobreira Gomes M; Clapauch R
    Maturitas; 2000 Jul; 36(1):69-74. PubMed ID: 10989244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of transdermal oestrogen therapy in postmenopausal women: a comparative study of an oestradiol gel and an oestradiol delivering patch.
    Hirvonen E; Cacciatore B; Wahlström T; Rita H; Wilén-Rosenqvist G
    Br J Obstet Gynaecol; 1997 Nov; 104 Suppl 16():26-31. PubMed ID: 9389780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intranasal versus transdermal matrix oestrogen replacement in Australasian women.
    Davis SR; Davison SL; Wilson S; Shepherd J; Lawton B
    Maturitas; 2005 Jun; 51(2):163-71. PubMed ID: 15917157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Skin reactions with transdermal estradiol therapy in a tropical environment.
    Bhathena RK; Anklesaria BS; Ganatra AM
    Int J Gynaecol Obstet; 1998 Feb; 60(2):177-9. PubMed ID: 9509960
    [No Abstract]   [Full Text] [Related]  

  • 15. Transdermal estradiol. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of menopausal complaints.
    Balfour JA; Heel RC
    Drugs; 1990 Oct; 40(4):561-82. PubMed ID: 2083514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative study to evaluate skin irritation and adhesion of Estradot and Climara in healthy postmenopausal women.
    Ibarra de Palacios P; Schmidt G; Sergejew T; Quebe-Fehling E; Lockhart L; Krinsky L
    Climacteric; 2002 Dec; 5(4):383-9. PubMed ID: 12626218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Skin reactions to transdermal estrogen replacement therapy in a tropical climate.
    de Cetina TC; Reyes LP
    Int J Gynaecol Obstet; 1999 Jan; 64(1):71-2. PubMed ID: 10190675
    [No Abstract]   [Full Text] [Related]  

  • 18. Acceptability and skin reactions to transdermal estrogen replacement therapy in relation to climate.
    Frenkel Y; Kopernik G; Lazer S; Tugendreich D; Zmira N; Oettinger M; Tendler R; Serr DM
    Maturitas; 1994 Nov; 20(1):31-6. PubMed ID: 7877518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanoparticle delivery for transdermal HRT.
    Valenzuela P; Simon JA
    Nanomedicine; 2012 Sep; 8 Suppl 1():S83-9. PubMed ID: 22640909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of a seven-day, transdermal estradiol drug-delivery system: comparison with conjugated estrogens and placebo. The Transdermal Estradiol Patch Study Group.
    Gordon SF; Thompson KA; Ruoff GE; Imig JR; Lane PJ; Schwenker CE
    Int J Fertil Menopausal Stud; 1995; 40(3):126-34. PubMed ID: 7663539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.